| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910978 | Lung Cancer | 2015 | 32 Pages |
Abstract
PD-L1 is expressed at high levels in a significant proportion of NSCLC and appears to be a favorable prognostic factor in early stage disease. As there are potential sampling limitations using tissue microarrays to assess heterogeneously expressed biomarkers, and as the results may differ in advanced stage disease, further studies are recommended.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Wendy A. Cooper, Thang Tran, Ricardo E. Vilain, Jason Madore, Christina I. Selinger, Maija Kohonen-Corish, PoYee Yip, Bing Yu, Sandra A. O'Toole, Brian C. McCaughan, Jennifer H. Yearley, Lisa G. Horvath, Steven Kao, Michael Boyer, Richard A. Scolyer,